"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
51,"no","yes","Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer",2016,"IJE","10.1093/ije/dyw129","Gao","Peter Kraft","pkraft@hsph.harvard.edu","Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA,","Effect of birthweight, childhood and adult body mass index, and waist-hip ratio on the risks of breast, ovarian, prostate, colorectal and lung cancer","Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Fehringer 2016 Breast All European both","18+","both","15748","18084","15748","18084",NA,"Healthy","European","BMI","childhood","Felix 2016 BMI, childhood European both",NA,"both","Not discussed","35668","Not discussed","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","r2  > 0.9","Not discussed",NA,NA,"15","15",NA,"Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni for 48 tests","SD","Case/control","OR","0.6",NA,"95","0.8","0.71","6.5*10-5","None",NA,"Discuss several: MR assumptions, limits of summary level approach, limited power","To test for and correct for bias due to pleiotropy where the InSIDE assumption holds, we performed Egger regression for all traits investigated","population stratification may be a source of confounding but the original studies saw little evidence for such bias and all have appropriately controlled for it.","Finally, the statistical power is limited by both the proportion of the adiposity risk factors explained by the genetic instruments, and the sample size in the cancer genetic association studies","Repeated analysis after removing overlapping loci, same results",861
51,"no","yes","Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer",2016,"IJE","10.1093/ije/dyw129","Gao","Peter Kraft","pkraft@hsph.harvard.edu","Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA,","Effect of birthweight, childhood and adult body mass index, and waist-hip ratio on the risks of breast, ovarian, prostate, colorectal and lung cancer","Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Fehringer 2016 Breast All European both","18+","both","15748","18084","15748","18084",NA,"Healthy","European","BMI","BMI","Locke 2015 BMI All ancestries both","18+","both","Not discussed","339224","Not discussed","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","r2  > 0.9","Not discussed",NA,NA,"77","97","Quote all ancestries N, use EU SNPs","Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni for 48 tests","SD","Case/control","OR","0.66",NA,"95","0.56999999999999995","0.77","2.5*10-7","None",NA,"Discuss several: MR assumptions, limits of summary level approach, limited power","To test for and correct for bias due to pleiotropy where the InSIDE assumption holds, we performed Egger regression for all traits investigated","population stratification may be a source of confounding but the original studies saw little evidence for such bias and all have appropriately controlled for it.","Finally, the statistical power is limited by both the proportion of the adiposity risk factors explained by the genetic instruments, and the sample size in the cancer genetic association studies","Repeated analysis after removing overlapping loci, same results",873
51,"no","yes","Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer",2016,"IJE","10.1093/ije/dyw129","Gao","Peter Kraft","pkraft@hsph.harvard.edu","Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA,","Effect of birthweight, childhood and adult body mass index, and waist-hip ratio on the risks of breast, ovarian, prostate, colorectal and lung cancer","Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Fehringer 2016 Breast All European both","18+","both","15748","18084","15748","18084",NA,"Healthy","European","BMI","childhood","Felix 2016 BMI, childhood European both",NA,"both","Not discussed","35668","Not discussed","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","r2  > 0.9","Not discussed",NA,NA,"15","15",NA,"Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni for 48 tests","SD","Case/control","OR","1.05",NA,"95","0.74","1.48","0.8","None",NA,"Discuss several: MR assumptions, limits of summary level approach, limited power","To test for and correct for bias due to pleiotropy where the InSIDE assumption holds, we performed Egger regression for all traits investigated","population stratification may be a source of confounding but the original studies saw little evidence for such bias and all have appropriately controlled for it.","Finally, the statistical power is limited by both the proportion of the adiposity risk factors explained by the genetic instruments, and the sample size in the cancer genetic association studies","Repeated analysis after removing overlapping loci, same results",897
51,"no","yes","Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer",2016,"IJE","10.1093/ije/dyw129","Gao","Peter Kraft","pkraft@hsph.harvard.edu","Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA,","Effect of birthweight, childhood and adult body mass index, and waist-hip ratio on the risks of breast, ovarian, prostate, colorectal and lung cancer","Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Fehringer 2016 Breast All European both","18+","both","15748","18084","15748","18084",NA,"Healthy","European","BMI","BMI","Locke 2015 BMI All ancestries both","18+","both","Not discussed","339224","Not discussed","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","r2  > 0.9","Not discussed",NA,NA,"77","97","Quote all ancestries N, use EU SNPs","Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Bonferroni for 48 tests","SD","Case/control","OR","0.75",NA,"95","0.62","0.92","4.7*10-3","None",NA,"Discuss several: MR assumptions, limits of summary level approach, limited power","To test for and correct for bias due to pleiotropy where the InSIDE assumption holds, we performed Egger regression for all traits investigated","population stratification may be a source of confounding but the original studies saw little evidence for such bias and all have appropriately controlled for it.","Finally, the statistical power is limited by both the proportion of the adiposity risk factors explained by the genetic instruments, and the sample size in the cancer genetic association studies","Repeated analysis after removing overlapping loci, same results",909
54,"no","yes","Effect of increased body mass index on risk of diagnosis or death from cancer",2019,"British Journal of Cancer","10.1038/s41416-019-0386-9","Gharahkhani","Puya Gharahkhani","Puya.Gharahkhani@qimrberghofer.edu.au","QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia","Effect of BMI on overall cancer risk and cancer mortality","High BMI is strongly associated with increased risk of various cancers.","One-sample","breast cancer","breast cancer","cancer","C50","Puya Gharahkhani  2019 Breast (C50) White-British both","40-69","both","11703",NA,"11703",NA,NA,"Breast (C50)","White-British","BMI","BMI","Puya Gharahkhani  2019 BMI White British adults both",NA,"Both","390628","390628",NA,"Healthy (cancer-free)","White-British","Age and sex","HRC ","0.01","To assess this assumption, we repeated the analyses by removing a subset of SNPs that were associated with potential confounders. These were identified by having a Bonferroni-corrected P < 1×10-5 for 520 SNPs tested in nine traits; smoking (four traits), alcohol intake (two traits), coffee/tea consumption (two traits), and height (one trait). In addition, to test for the presence of directional pleiotropy, we used two approaches: (1) we created funnel plots for the MR estimates for all SNPs used as instrumental variable, where asymmetry in the funnel plots indicates directional pleiotropy; and (2) we used the MR Egger regression approach where a non-zero intercept indicates presence of directional pleiotropy.2","1x10-8","Not discussed","Not discussed","Not discussed",NA,"520",NA,"520",NA,"Not discussed",NA,"Inverse variance weighted (fixed effects)","Re-ran analysis using subset of SNPs, having removed SNPs associated with potential confounders","Funnel plot","MR Egger",NA,NA,"We repeated the analyses by removing a subset of SNPs that were associated with potential confounders. These were identified by having a Bonferroni-corrected P < 1×10-5 for 520 SNPs tested in nine traits; smoking (four traits), alcohol intake (two traits), coffee/tea consumption (two traits), and height (one trait). In addition, to test for the presence of directional pleiotropy.","r2 (7%) and F statistic","Not discussed","Not discussed","Not discussed","No","No","SD","case/control","OR","1.01",NA,"95","0.93","1.1000000000000001","7.53x10-1",NA,NA,"Did not investigate the causal effect of obesity as a dichotomous risk factor. MR model assumed a linear relationship between genetically predicted BMI with cancer risk and mortality. Did not investigate the effect of BMI on cancer mortality in prevalent and incident cancers, separately. Overall cancer phenotype may be rather hetero- geneous","Not discussed","Used a homogenous population with all the participants being of white-British ancestry","Statistical power was quite low for a conclusive interpretation of the non-significant individual cancer results",NA,972
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","breast cancer","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","46235","42482","46235","42482",NA,"Case/control","European","BMI","BMI > 25.5-25.9 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","88807","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.95",NA,"95","0.87","1.02",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1046
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","breast cancer","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","46235","42482","46235","42482",NA,"Case/control","European","BMI","BMI > 26-26.5 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","88807","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.9",NA,"95","0.82","0.98",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1057
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","breast cancer","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","46235","42482","46235","42482",NA,"Case/control","European","BMI","BMI > 26.5 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","88807","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.84",NA,"95","0.71","0.97",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1068
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","breast cancer","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","46235","42482","46235","42482",NA,"Case/control","European","BMI","5kg/m2 increase in BMI","Locke 2015 BMI European adults both",NA,"female","88807","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.65",NA,"95","0.56000000000000005","0.75","3.32 × 10−10",NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1079
116,"yes","yes","Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects",2019,"Nature Communications","10.1038/s41467-019-09432-2","Qi","Nilanjan Chatterjee","nilanjan@jhu.edu","12 Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA., Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","Method: Effect of body mass index on coronary artery disease, breast cancer, and major depressive disorder","Method paper proposing a novel approach for robust and efficient MR analysis using large number of genetic instruments, based on a novel spike-detection algorithm under a normal-mixture model for underlying effect-size distributions.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Michailidou  2017 Breast Cancer  European and East Asian  female","Not discussed","female","Not discussed","Not discussed","137045","119078",NA,"Case/control","European and east asian","BMI","BMI","Yengo 2018 BMI Europeans both","18+","both","Not discussed","681275",NA,"Healthy","European","Not discussed","HapMap3","R2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,"839",NA,"941","Not discussed","Not discussed",NA,"Inverse variance weighted","MR Egger","Weighted median","Weighted mode",NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Case/control","log-OR","-0.1",NA,"95","-0.16","-0.05","Not discussed","Not discussed","Not discussed","Method comparison paper using BMI as example. Only discussed method not the example","Not discussed","Not discussed","Not discussed",NA,1502
116,"yes","yes","Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects",2019,"Nature Communications","10.1038/s41467-019-09432-2","Qi","Nilanjan Chatterjee","nilanjan@jhu.edu","12 Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA., Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","Method: Effect of body mass index on coronary artery disease, breast cancer, and major depressive disorder","Method paper proposing a novel approach for robust and efficient MR analysis using large number of genetic instruments, based on a novel spike-detection algorithm under a normal-mixture model for underlying effect-size distributions.","Two-sample summary-level","breast cancer","breast cancer","cancer","Defined in individual GWASs","Michailidou  2017 Breast Cancer  European and East Asian  female","Not discussed","female","Not discussed","Not discussed","137045","119078",NA,"Case/control","European and east asian","BMI","BMI","Yengo 2018 BMI Europeans both","18+","both","Not discussed","681275",NA,"Healthy","European","Not discussed","HapMap3","R2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,"839",NA,"941","Not discussed","Not discussed",NA,"MRMix","MR Egger","Weighted median","Weighted mode",NA,NA,"Consistent with main analysis","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Case/control","log-OR","-0.18",NA,"95","-0.28000000000000003","-0.08","Not discussed","Not discussed","Not discussed","Method comparison paper using BMI as example. Only discussed method not the example","Not discussed","Not discussed","Not discussed",NA,1505
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","one-sample meta-analysis","breast cancer","breast cancer","cancer","Not discussed","Current study","55±12","female","98842","83464",NA,NA,NA,"case/control","European ancestry","BMI","BMI","Not discussed","Not discussed","Not discussed","182306","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,NA,"166",NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed",NA,"Logistic regression model","Not discussed",NA,NA,NA,NA,"Associations of wPRSs with breast cancer risk were evaluated separately in the iCOGs and OncoArray datasets by  treating these scores as continuous variables. A logistic regression was performed with age at interview/diagnosis, study site/country and PCs as covariates. The results were then combined using meta-analyses in METAL with a fixed effects model.","F-statistic = 32.6","R","Not discussed","Not discussed","Not discussed","Not discussed","SD","Case/control","OR","0.76",NA,"95","0.72","0.8","5.2500000000000003E-22",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1607
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","one-sample meta-analysis","breast cancer","breast cancer","cancer","Not discussed","Current study","55±12","female","98842","83464",NA,NA,NA,"case/control","European ancestry","BMI","per 5 units increase","Not discussed","Not discussed","Not discussed","182306","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,NA,"166",NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI).","Not discussed",NA,"Logistic regression model","Not discussed",NA,NA,NA,NA,"Associations of wPRSs with breast cancer risk were evaluated separately in the iCOGs and OncoArray datasets by  treating these scores as continuous variables. A logistic regression was performed with age at interview/diagnosis, study site/country and PCs as covariates. The results were then combined using meta-analyses in METAL with a fixed effects model.","F-statistic = 32.6","R","Not discussed","Not discussed","Not discussed","Not discussed","per 5 kg/m2","Case/control","OR","0.7",NA,"95","0.65","0.76","5.2500000000000003E-22",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1608
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","one-sample meta-analysis","breast cancer","breast cancer","cancer","Not discussed","Current study","55±12","female","98842","83464",NA,NA,NA,"case/control","European ancestry","BMI","excluded pleiotropic SNPs","Not discussed","Not discussed","Not discussed","182306","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,NA,"162",NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed",NA,"Logistic regression model","Not discussed",NA,NA,NA,NA,"Associations of wPRSs with breast cancer risk were evaluated separately in the iCOGs and OncoArray datasets by  treating these scores as continuous variables. A logistic regression was performed with age at interview/diagnosis, study site/country and PCs as covariates. The results were then combined using meta-analyses in METAL with a fixed effects model.","F-statistic = 32.3","R","Not discussed","Not discussed","Not discussed","Not discussed","SD","Case/control","OR","0.77",NA,"95","0.73","0.82","5.0500000000000001E-19",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1610
129,"no","yes","Associations of obesity and circulating
 insulin and glucose with breast cancer risk:
 a Mendelian randomization analysis",2018,"International Journal of Epidemiology","10.1093/ije/dyy201","Shu","Wei Zheng","wei.zheng@vanderbilt.edu","Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN 37203-1738, USA","Effect of adiposity measures on type 2 diabetes and breast cancer","In addition to the established association between general obesity and
breast cancer risk, central obesity and circulating fasting insulin and glucose have been
linked to the development of this common malignancy. Findings from previous studies,
however, have been inconsistent, and the nature of the associations is unclear.","one-sample meta-analysis","breast cancer","breast cancer","cancer","Not discussed","Current study","55±12","female","98842","83464",NA,NA,NA,"case/control","European ancestry","BMI","excluded pleiotropic SNPs, per five units","Not discussed","Not discussed","Not discussed","182306","Not discussed","SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed","European","Not discussed","Not discussed","r2 < 0.1","Not discussed","4.9999999999999998E-8","Not discussed","Not discussed","Not discussed",NA,NA,"162",NA,"SNPs were selected from multiple studies by searching the National Human Genome Research Institute-European Bioinformatics Institute Catalogof Published Genome-Wide Association Studies and the literaturefor SNPs associated with the following traits: levels of2-h glucose (2hrGlu), fasting glucose (FG), fasting insulin(FI), BMI and waist-hip-ratio with adjustment of BMI(WHRadj BMI). SNPs for each trait excluded pleiotropic SNPs and the SNPs associated with the other four traits of interest.","Not discussed",NA,"Logistic regression model","Not discussed",NA,NA,NA,NA,"Associations of wPRSs with breast cancer risk were evaluated separately in the iCOGs and OncoArray datasets by  treating these scores as continuous variables. A logistic regression was performed with age at interview/diagnosis, study site/country and PCs as covariates. The results were then combined using meta-analyses in METAL with a fixed effects model.","F-statistic = 32.3","R","Not discussed","Not discussed","Not discussed","Not discussed","per 5 kg/m2","Case/control","OR","0.7",NA,"95","0.66","0.77","5.0500000000000001E-19",NA,NA,"Pleiotropy effect exist in obesity association studies; statistical power might be low because of low variance explained by IVs.","Pleiotropy was found for the associations of obesity, but it is not likely that the observed associations can be primarily explained by pleiotropic effects.","Not discussed","Our ability to perform Mendelianrandomization analysis is limited by the genetic variants identified to date in GWAS, and the variance explained bythese genetic variants for some traits is small. We used 10 instruments in our main analysis, which could lead to false positive findings due to multiple comparisons. However, the associations reported in this study for 2-h glucose, fastinginsulin, BMI and WHRadj BMI were robust, reaching thestringent Bonferroni corrected significance level (P < 0.005).",NA,1611
